Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

38

Revenue 2017

Imbruvica

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Imbruvica was produced by Johnson & Johnson.

EU grants approval for Venclyxto/Gazyvaro combo in CLL

EU grants approval for Venclyxto/Gazyvaro combo in CLL

It also has to contend with the combination of AbbVie’s Imbruvica (ibrutinib) plus Gazyvaro, which became the first chemo-free option for first-line CLL therapy last year.

AZ revenues rise, but it says coronavirus could hit 2020

AZ revenues rise, but it says coronavirus could hit 2020 Recently-approved for a new chronic lymphocytic leukaemia (CLL) indication, AZ’s rival to Johnson &Johnson’s blockbuster BTK inhibitor Imbruvica (ibrutinib) – Calquence (acalabrutinib) – also gathered momentum and contributed $56m in

FDA starts priority review of Kite’s CAR-T for mantle cell lymphoma

FDA starts priority review of Kite’s CAR-T for mantle cell lymphoma Other treatment options for advanced MCL include BeiGene’s recently approved BTK inhibitor Brukinsa (zanubrutinib) and AbbVie/Johnson &Johnson’s established BTK inhibitor Imbruvica (ibrutinib).

Skyrizi, Rinvoq help AbbVie weather Humira slowdown

Skyrizi, Rinvoq help AbbVie weather Humira slowdown Outside its critical immunology franchise there were also gains for blood cancer therapy Imbruvica (ibrutinib), up almost 29% to $1.3bn, as well as a $251m contribution from newer therapy Venclexta

EMA begins review of Kite’s CAR-T for mantle cell lymphoma

EMA begins review of Kite’s CAR-T for mantle cell lymphoma Current treatment options for MCL include AstraZeneca’s BTK inhibitor  Calquence (acalabrutinib) and Johnson &Johnson/AbbVie’s BTK inhibitor Imbruvica (ibrutinib).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

The big issue
Whether you want to lead or follow, you need to understand the elephant in the C-suite...
INFOGRAPHIC 02: The Importance of clinical study websites
Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
Working with, Advocating for, and Empowering Patients
A holistic view of how to work with patients virtually...

Infographics